Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

Background: The human gut harbors around 10<sup>13</sup>–10<sup>14</sup> microorganisms, collectively referred to as gut microbiota. Recent studies have found that the gut microbiota may have an impact on the interaction between immune regulation and anti-cancer immunotherapi...

Full description

Bibliographic Details
Main Authors: Feiyu Zhang, Macarena Ferrero, Ning Dong, Giuseppe D’Auria, Mariana Reyes-Prieto, Alejandro Herreros-Pomares, Silvia Calabuig-Fariñas, Elena Duréndez, Francisco Aparisi, Ana Blasco, Clara García, Carlos Camps, Eloisa Jantus-Lewintre, Rafael Sirera
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
gut microbiota
biomarker
non-small cell lung cancer
immune checkpoint blockade
immunotherapy
next-generation sequencing
Online Access:https://www.mdpi.com/2072-6694/13/11/2514

Internet

https://www.mdpi.com/2072-6694/13/11/2514

Similar Items